Detalhe da pesquisa
1.
Randomized trial of asunaprevir plus peginterferon alfa and ribavirin for previously untreated genotype 1 or 4 chronic hepatitis C.
J Hepatol
; 61(6): 1220-7, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25038486
2.
Telaprevir for retreatment of HCV infection.
N Engl J Med
; 364(25): 2417-28, 2011 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21696308
3.
Telaprevir for previously untreated chronic hepatitis C virus infection.
N Engl J Med
; 364(25): 2405-16, 2011 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21696307
4.
Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C.
Gastroenterology
; 140(7): 1990-9, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21419770
5.
FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ program.
J Hepatol
; 54(2): 227-35, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21056496
6.
Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy.
Gastroenterology
; 136(5): 1618-28.e2, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19208349
7.
[Treatment of non-responders]. / Tratamiento en no respondedores.
Acta Gastroenterol Latinoam
; 35 Suppl 1: S41-2, 2005 Jun.
Artigo
em Espanhol
| MEDLINE | ID: mdl-20214299